Clinical trials for Autosomal recessive polycystic kidney disease

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Autosomal recessive polycystic kidney disease. For all clinical trials, go to clinical trials search

This list shows clinical trials for Autosomal recessive polycystic kidney disease

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Autosomal recessive polycystic kidney disease
Title Recruitment status Location
Genetic Studies of Insulin and Diabetes Recruiting United Kingdom
A 24-week, Phase IIB, Randomized, Active-controlled, Parallel Group, Multi-center Study to Evaluate the Safety and Efficacy of GSK1278863 in Subjects With Anemia Associated With Chronic Kidney Diseases Who Are Not on Dialysis. Recruiting United Kingdom
Open-label Trial to Evaluate the Long Term Safety of Titrated Immediate-release Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease Recruiting United Kingdom
An international registry study on autosomal recessive polycystic kidney disease (ARPKD) Recruiting United Kingdom
The Eurocyst Initiative: Building a Network of ADPKD Reference Centers Across Europe Recruiting United Kingdom
Pathway to Prevention Study Recruiting United Kingdom
Accuracy of Glomerular Filtration Rate (GFR) Estimation Using Creatinine and Cystatin C and Albuminuria Recruiting United Kingdom
Auto-regulation & cerebral blood flow in transient ischaemic attack (TIA) patients Recruiting United Kingdom
The Eurocyst Initiative: Building a Reference Center Network Across EUROpe to Establish a Large-scale Longitudinal Observational Cohort of Autosomal Dominant polyCYSTic Kidney Disease (ADPKD) Patients Recruiting United Kingdom
Anakinra vs. Steroids for the Treatment of Gout Attacks in Patients With Renal Disease (ASGARD): A Feasibility Study Recruiting United Kingdom

Page last reviewed:

Next review due: